2.1 dosing information the dose of austedo xr and austedo is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability In a cohort of 27 participants, up to 77% reported enhancements in daily activities such as speech and eating after three months of treatment. Table 1 displays the recommended dosage and important administration instructions of austedo xr and austedo when first prescribed to patients who are not being switched from tetrabenazine (a related vmat2 inhibitor).
Amanda Marie aka Bananaamarie Nude Leaks OnlyFans - Fapellas
Austedo's drug class is a vmat2 inhibitor (vesicular monoamine transporter 2 inhibitor)
What is tardive dyskinesia (td) and chorea associated with huntington’s disease
